ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

ORIC Pharmaceuticals at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

ORIC Pharmaceuticals takes part in 1 session at ESMO 2026 in Madrid, and exhibits at Booth 8103. Its session covers how the PRC2-blocking drug rinzimetostat affects cell identity and androgen-receptor signaling in prostate cancer, including preclinical models and patient samples.

OrganizationESMO 2026 Attendance
BiotechExhibitor
Clinical-stage oncology company developing treatments against cancer resistance mechanisms, with programs in prostate and lung cancer.
Booth
Exhibiting at Booth 8103

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at ORIC Pharmaceuticals

Tell us what you sell and we’ll find the people at ORIC Pharmaceuticals most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction